CorMedix CRMD Accrued liabilities
Accrued liabilities at other companies
Other financials
Where this comes from
Reported directly by CorMedix in its filing.
Tagged under the XBRL concept us-gaap:IncreaseDecreaseInAccruedLiabilities.
The official record: CorMedix’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →
Ask your AI about CorMedix's accrued liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is CorMedix's accrued liabilities?
- CorMedix (CRMD) reported accrued liabilities of -$50.62M in Q1 2026.
- How has CorMedix's accrued liabilities changed year-over-year?
- CorMedix's accrued liabilities decreased by 15373.2% year-over-year, from $331.44K to -$50.62M.
- What is the long-term trend for CorMedix's accrued liabilities?
- Over 2 years (2023 to 2025), CorMedix's accrued liabilities has grown at a 480.0% compound annual growth rate (CAGR), from $3M to $100.77M.
- What does accrued liabilities mean?
- The net change in obligations for expenses incurred but not yet invoiced or paid by the end of the reporting period. This reflects the company's short-term operational commitments and the timing of expense recognition versus cash disbursement.